Providing stock analysis for investors of the Canadian junior markets
PharmaDrug (CSE: PHRX) has seen its joint venture with PharmaTher Holdings (CSE: PHRM) begin to bear fruit. The venture, referred to as Sairiyo Therapeutics, has seen a milestone in the development of Cepharanthine, also known as PD-001.
Read more
Shortly after a Delaware judge voided Tesla (Nasdaq: TSLA) CEO Elon Musk’s $55 billion compensation package, which significantly eroded his
Read more
Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that it will be conducting a
Read more
Numinus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in Alto Neuroscience, a clinical-stage biopharma
Read more
The Securities and Exchange Commission (SEC) has charged Laura Tyler Perryman, co-founder and former CEO of medical device startup Stimwave
Read more
Ozempic for diabetes and Wegovy for weight loss have been so wildly in demand that the drugs boosted the GDP
Read more
Moderna (NASDAQ: MRNA), the Boston-based pharmaceutical company known for its mRNA Covid-19 vaccine, has reportedly enlisted the services of former
Read more
Neuralink, a biotech company founded by Elon Musk, managed to raise $323.2 million in a fresh equity funding round based
Read more
GLP-1 medications like Ozempic and Wegovy could mean serious trouble for the quick-service restaurant (QSR) industry. Recent insights from Earnest
Read more
On Monday, Swiss healthcare firm Roche made a significant announcement, revealing its acquisition of Telavant Holdings for a substantial upfront
Read more